Login / Signup

Predictive value of next-generation sequencing-based minimal residual disease after CAR-T cell therapy.

Yue HuangHouli ZhaoMi ShaoLinghui ZhouXiaoqing LiGuoqing WeiWenjun WuJiazhen CuiAlex H ChangTao SunYongxian HuHe Huang
Published in: Bone marrow transplantation (2022)
Keyphrases
  • cell therapy
  • copy number
  • stem cells
  • circulating tumor
  • mesenchymal stem cells
  • gene expression
  • genome wide
  • bone marrow
  • cell free